APrevent^® VOIS

APrevent^® VOIS, a class IIb long term implantable medical device, receives the approval of CE mark from notified body in Dec 2019. It shows the significant that APrevent® VOIS is going to launch EU market to approach more patients suffering from glottic insufficiency by 2020.